4//SEC Filing
Cobb Paula K 4
Accession 0001209191-19-035551
CIK 0001711675other
Filed
Jun 6, 8:00 PM ET
Accepted
Jun 7, 4:32 PM ET
Size
8.5 KB
Accession
0001209191-19-035551
Insider Transaction Report
Form 4
Cobb Paula K
Director
Transactions
- Disposition to Issuer
Stock Option (Right to Buy)
2019-06-07$0.34/sh−36,400$12,376→ 0 totalExercise: $25.16Exp: 2028-09-11→ Ordinary Shares (36,400 underlying) - Disposition to Issuer
Stock Option (Right to Buy)
2019-06-07$11.93/sh−21,000$250,530→ 0 totalExercise: $13.57Exp: 2029-01-24→ Ordinary Shares (21,000 underlying)
Footnotes (3)
- [F1]In connection with the acquisition by Tungsten Bidco Limited of the entire issued and to be issued share capital of Nightstar Therapeutics plc (the "Issuer") on June 7, 2019 by means of a scheme of arrangement under Part 26 of the UK Companies Act 2006, all stock options were cancelled in exchange for a payment equal to $25.50 with respect to each ordinary share subject to the option award, less the applicable exercise price.
- [F2]The ordinary shares, nominal value GBP 0.01 per share, of the Issuer may be represented by American Depositary Shares ("ADSs"). Each ADS represents one ordinary share of the Issuer.
- [F3]Represents the payment per share received in exchange for the cancellation of each option of $25.50, less the applicable exercise price.
Documents
Issuer
Nightstar Therapeutics plc
CIK 0001711675
Entity typeother
Related Parties
1- filerCIK 0001763372
Filing Metadata
- Form type
- 4
- Filed
- Jun 6, 8:00 PM ET
- Accepted
- Jun 7, 4:32 PM ET
- Size
- 8.5 KB